AzTrials
AzTrials

Patients Who Are Diagnosed to Have Intracranial LesionsNCT04569526

Ultrasonography Guided Brain Lesions Resection:

An observational study of Patients Who Are Diagnosed to Have Intracranial Lesions, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1. Evaluate the clinical value of intraoperative ultrasonography as a real-time guidance 2. Combination of data of MRI Tractography and intra operative ultrasonography will be useful in good localization of lesions or not . 3. Maximal safe resection . Read more about this study

Who is it for?
Ages 1 month to 70 years
What is being tested?
use of intraoperative ultrasound
Type of treatment
Medical device
How many people
1 participants
Where
No sites listed yet
Study dates
25 Sep 2020to 30 Dec 2021
How long will I take part?
1 Month
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 70 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Patients diagnosed to have brain lesion, selected based on the inclusion and exclusion criteria

Who may be able to join

  • Patients who are diagnosed to have Intracranial lesions Patients with recurrent lesions

Who cannot join

  • Patients who are unfit for surgery Patients who have multifocal lesions

Trial locations and contacts

No sites are listed yet.

sarah ahmed saad tawfik, Rdr contact

01099842575 ext. 002

sarahahmedsaad@gmail.com

About this study

Official title: Ultrasonography Guided Brain Lesions Resection: a Tool for a Real Time Intraoperative Neuronavigation

  1. Evaluate the clinical value of intraoperative ultrasonography as a real-time guidance
  2. Combination of data of MRI Tractography and intra operative ultrasonography will be useful in good localization of lesions or not .
  3. Maximal safe resection .
Read the detailed description

Accurate pre and intraoperative localization of Brain lesions is a challenge in neurosurgery specially deep intra cerebral lesions. Stereotaxy and neuronavigator played a major role in preoperative and intraoperative evaluation of exact location of intra cerebral lesions, the main drawbacks of using steriotaxy and neuronavigator that they are time consuming, complicated and expensive.(1) Nowadays we use MRI Tractography as preoperative imaging to localize lesions and there relation to neural tracts specially in eloquent brain areas, and also intraoperative ultrasonography Which act as a real-time, unexpansive and relatively simple tool for intraoperative visualization of the lesion's location, size, extent and its relationship with the surrounding tissue, also it can reveal the lesion's blood supply, it can measure the rate and direction of arterial blood flow.(2,3,4) Intraoperative ultrasonic imaging was first applied as a real-time navigation system in neurosurgery in 1980. (5) In this research we will combine the use of preoperative MRI tractography with intra operative ultrasonography in accurate localization of brain lesions and its relation with important tracts and if this combination will be beneficial and add to the safety of excision of lesions or not.

Being tested
use of intraoperative ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • use of intraoperative ultrasoundDevice

    Ultrasonography guided brain lesions resection intra operatively for good localization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Extent of resection of the lesion

    Extent of resection of the lesion evaluated by comparing pre operative and post operative MRI

    Measured: 48 hours

Secondary outcomes (1)
  1. post operative complication

    post operative complication evaluated by full neurological examination

    Measured: one month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Sep 2020
  2. Study start25 Sep 2020 (estimated)
  3. Primary completion25 Jul 2021 (estimated)
  4. Study completion30 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1 participants (estimated)
Target duration
1 Month
IDs, dates and publications
ClinicalTrials.gov ID
NCT04569526
Sponsor's protocol ID
intra operative ultrasound
Status last verified
Sep 2020
First submitted
24 Sep 2020
Last updated
30 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Patients Who Are Diagnosed to Have Intracranial Lesions, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact sarah ahmed saad tawfik, Rdr (01099842575 ext. 002, sarahahmedsaad@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Extent of resection of the lesion (time frame: 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in